-
3rd Annual Portfolio Management Strategies for Biosimilars & Generics
Acknowledge New Trends in Profitable Markets, Seek for Strategic Alliances to Improve Marketing and Commercial Strategies, Understand Stakeholder’s Opinions
26-27 Sep 2019
World Trade Center Barcelona, Spain
- call back request
- Conference Speakers
-
Erez Hybloom
Former Senior Director, Global Portfolio and Europe Portfolio
Teva
Amit Bansal
Divestment Lead
Sanofi
Detlef Behrens
Head of CMO
Biocon
Nicola Travierso
President
Velit Biopharmaceuticals
Bjarni Baerings
President
Hetero
Sameer Agarwal
CEO
CSA Healthcare
Ana Gavaldá
Managing Director
Annion Pharma
Joanna T. Brougher
Founder & Principal
BioPharma Law Group, PLLC
- General Enquiries
-
Constandinos Vinall
marcus evans (Europe) Ltd
PO Box 24797
1304 Nicosia, Cyprus
Telephone: +357 22849 380
Fax: +357 22849 394
Email: constandinosv@marcusevanscy.com
- Conference Quote
-
Acknowledge New Trends in Profitable Markets —Value-added/Complex generics & Biosimilars—, Seek for Strategic Alliances to Improve Marketing and Commercial Strategies, Understand Stakeholder's Opinions to Success in different Markets. Find out more